In this review the histaminergic ligands for the histamine H-1, H-2 and H-3
receptors, which are currently used as tools in pharmacological studies, a
re described. To study interactions with the histamine H-1, receptor, the H
-1 agonist 2-aminoethylthiazole has long since been used. However, during t
he last decade. 2-phenylhistamine derivatives emerged with interesting bind
ing features. So far no radiolabelled selective H-1 agonist has been common
ly used. As H-1 antagonists mepyramine, triprolidine and chlorpheniramine a
re described together with radiolabelled H-1 antagonists [H-3]mepyramine an
d [H-3]doxepin. Special attention has been paid to the PET ligands [C-11]do
xepin and [C-11]mepyramine and the [I-125] labelled antagonists [I-125]iodo
bolpyramine and [I-125]iodoazidophenpyramine. Concerning H-2 agonists, espe
cially dimaprit, amthamine and impromidine are discussed. There are several
H-2 antagonists; amongst them cimetidine, tiotidine and ranitidine are use
d most frequently. Many of these antagonists behave as inverse agonists. As
radiolabelled H-2 antagonists, [H-3]cimetidine, [H-3]tiotidine, [I-125]iod
oaminopotentidine and [I-125]iodoazidopotentidine are included. Commonly us
ed histamine H-3 agonists are N-alpha-methylhistamine, (R)alpha-methylhista
mine, imetit and immepip. Both methylhistamines are also available as [H-3]
labelled ligands. As reference compounds, often used H-3 antagonists are t
hioperamide; clobenpropit, iodophenpropit and impentamine. Most important r
adiolabelled H-3 antagonists are S-[H-3]methylthioperamide, [H-3]thioperami
de, [I-125]iodophenpropit and [I-125]iodoproxyfan. The use of all these com
pounds as a tool in pharmacology is also discussed. (C) 2000 Editions scien
tifiques et medicales Elsevier SAS.